<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Haptoglobin (Hp), an Hb-binding plasma protein, exists in two major allelic variants </plain></SENT>
<SENT sid="1" pm="."><plain>Hp1 has higher Hb binding and <z:chebi fb="11" ids="22586">antioxidant</z:chebi> capacity compared with Hp2 </plain></SENT>
<SENT sid="2" pm="."><plain>Individuals with Hp1 exhibit a lower incidence of <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">angiopathies</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0009800'>Gestational diabetes</z:hpo> mellitus (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e>) is an early manifestation of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in pregnant women </plain></SENT>
<SENT sid="4" pm="."><plain>It is usually confined to the time of gestation, but carries an increased risk to develop type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> later in life </plain></SENT>
<SENT sid="5" pm="."><plain>RESEARCH DESIGN AND METHODS: From consecutive Caucasian pregnant women (n = 250) referred for oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance testing, the Hp phenotype was determined </plain></SENT>
<SENT sid="6" pm="."><plain>Significance of distribution and odds ratios (ORs) associated with Hp phenotype were calculated for women with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> (n = 110) and women with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance (n = 140) </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: -Frequency of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> in Hp phenotype classes increased with the number of Hp2 alleles (P &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>ORs for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> in women heterozygous and homozygous for Hp2 were 2.7 (95% CI 1.06-6.84) and 4.2 (1.67-10.55), respectively </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Hp phenotype is an apparent risk factor for the development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> in our study population </plain></SENT>
<SENT sid="10" pm="."><plain>This might be due to the low antioxidative potential of Hp2 compared with Hp1 </plain></SENT>
</text></document>